Incyte: Latest News, Top Stories & Analysis

WILMINGTON, DE — Biopharmaceutical company Incyte (Nasdaq: INCY) has reported encouraging results from its Phase 3 STOP-HS clinical trials evaluating povorcitinib, an oral JAK1 inhibitor, for moderate to severe hidradenitis suppurativa …

Regional

Incyte Expands Delaware Presence with New Wilmington Buildings

May 28, 2024May 27, 2024 - by Timothy Alexander

WILMINGTON, DE — Incyte (Nasdaq: INCY) announced its expansion in Delaware with the acquisition of two buildings in downtown Wilmington. Located at 1100 North King Street and 1100 North French …